MAP1LC3A and neoplasm: Immunohistochemical (IHC) analysis showed that the animals injected with SIRT7-depleted 22Rv1 cells had a lower percentage proliferation of Ki67+ and LC3+ tumor cells than mice administered wild type 22Rv1 cells (Fig. 4d).